HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chung, J.-K. Articles by Lee, M. C. Search for Related Content PubMed PubMed Citation Articles by Chung, J.-K. Articles by Lee, M. C.

Mechanisms Related to [¹⁸F]Fluorodeoxyglucose Uptake of Human Colon Cancers Transplanted in Nude Mice

Departments of Nuclear Medicine and Pathology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
Ewha Womans University College of Pharmacy, Seoul, Korea

Correspondence: For correspondence or reprints contact: June-Key Chung, MD, Department of Nuclear Medicine, Seoul National University Hospital, 28 Yungundong, Chongno-gu, Seoul 110–744, Korea.

ABSTRACT

[¹⁸F]Fluorodeoxyglucose ([¹⁸F]FDG), a glucose analogue, has been widely used for tumor imaging. To investigate the mechanisms related to [¹⁸F]FDG uptake by tumors, an experiment involving nude mice was performed. Methods: Human colon cancer cell lines SNU-C2A, SNU-C4 and SNU-C5 were transplanted to nude mice. Using immunohistochemical staining and Western blot, the expression of glucose transporter (Glut) isoforms (Glut-15) in xenografted tumors was analyzed. For the analysis of messenger ribonucleic acid (mRNA) expression, reverse-transcription polymerase chain reaction and Northern blot were used and the enzyme activity of hexokinase in cancer tissues was measured by continuous spectrophotometric rate determination. Results: [¹⁸F]FDG uptake in SNU-C4 and SNU-C5 cells was higher than in normal colon cells. Among these cells and xenografted tumors, SNU-C5 showed the highest level of [¹⁸F]FDG uptake, followed by SNU-C4 and SNU-C2A. An immunostamning experiment showed intense staining of Glut-1 in SNU-C5 tumors but somewhat faint staining in SNU-C4. SNU-C5 tumors also showed positive staining with Glut-3, although this was not the case with SNU-C2A and SNU-C4. Western blot analysis showed the expression of Glut-1 and Glut-3 in all tumors. Experiments involving Northern blot analysis and reverse transcription polymerase chain reaction confirmed the overexpression of Glut-1 mRNA in all tumors, with the highest level in SNU-C5. The level of Glut-3 mRNA was also elevated in SNU-C5 tumors but not in SNU-C2A and SNU-C4. The enzyme activity of hexokinase did not vary among different tumors. Conclusion: Gluts, especially Glut-1, are responsible for [¹⁸F]FDG uptakein a nude mouse model of colon cancer rather than hexokinase activity. Increased numbers of glucose transporters at the plasma membrane of cancer cells is attributed to an increased level of transcripts of glucose transporter genes and may be a cause of increased [¹⁸F]FDG uptake, at least in colon cancer tumors.

Key Words: colon cancer • [¹⁸F]fluorodeoxyglucose • glucose transporter • glucose transporter messenger ribonucleic acid • hexokinase

This article has been cited by other articles:

				T. Tsujikawa, Y. Yoshida, T. Mori, T. Kurokawa, Y. Fujibayashi, F. Kotsuji, and H. Okazawa Uterine Tumors: Pathophysiologic Imaging with 16{alpha}-[18F]fluoro-17{beta}-estradiol and 18F Fluorodeoxyglucose PET--Initial Experience Radiology, August 1, 2008; 248(2): 599 - 605. [Abstract] [Full Text] [PDF]

				A Saleem Potential of PET in oncology and radiotherapy Br. J. Radiol., November 1, 2005; Supplement_28(1): 6 - 16. [Full Text] [PDF]

				A. Luciani, J.-C. Olivier, O. Clement, N. Siauve, P.-Y. Brillet, B. Bessoud, F. Gazeau, I. F. Uchegbu, E. Kahn, G. Frija, et al. Glucose-Receptor MR Imaging of Tumors: Study in Mice with PEGylated Paramagnetic Niosomes Radiology, April 1, 2004; 231(1): 135 - 142. [Abstract] [Full Text] [PDF]